Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Lack of Association of Proteinuria and Clinical Outcome in Patients Treated with Bevacizumab for Metastatic Colorectal Cancer

SATORU IWASA, TAKAKO EGUCHI NAKAJIMA, KENGO NAGASHIMA, YOSHITAKA HONMA, KEN KATO, TETSUYA HAMAGUCHI, YASUHIDE YAMADA and YASUHIRO SHIMADA
Anticancer Research January 2013, 33 (1) 309-316;
SATORU IWASA
1Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAKO EGUCHI NAKAJIMA
1Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan
2Department of Clinical Oncology, St. Marianna University, School of Medicine, Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tnakajima{at}marianna-u.ac.jp
KENGO NAGASHIMA
3Laboratory of Biostatistics, Faculty of Pharmaceutical Sciences, Josai University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHITAKA HONMA
1Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEN KATO
1Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TETSUYA HAMAGUCHI
1Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHIDE YAMADA
1Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHIRO SHIMADA
1Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Time of onset of proteinuria after bevacizumab therapy.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Kaplan–Meier estimates of progression-free survival for patients with grade 0-2 proteinuria.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Kaplan–Meier estimates of overall survival for patients with grade 0-2 proteinuria.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table IIIA.
  • Table IIIB.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 33, Issue 1
January 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lack of Association of Proteinuria and Clinical Outcome in Patients Treated with Bevacizumab for Metastatic Colorectal Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Lack of Association of Proteinuria and Clinical Outcome in Patients Treated with Bevacizumab for Metastatic Colorectal Cancer
SATORU IWASA, TAKAKO EGUCHI NAKAJIMA, KENGO NAGASHIMA, YOSHITAKA HONMA, KEN KATO, TETSUYA HAMAGUCHI, YASUHIDE YAMADA, YASUHIRO SHIMADA
Anticancer Research Jan 2013, 33 (1) 309-316;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Lack of Association of Proteinuria and Clinical Outcome in Patients Treated with Bevacizumab for Metastatic Colorectal Cancer
SATORU IWASA, TAKAKO EGUCHI NAKAJIMA, KENGO NAGASHIMA, YOSHITAKA HONMA, KEN KATO, TETSUYA HAMAGUCHI, YASUHIDE YAMADA, YASUHIRO SHIMADA
Anticancer Research Jan 2013, 33 (1) 309-316;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Clinical Relevance of the CALLY Index in Prognostic Stratification of Intrahepatic Cholangiocarcinoma
  • Geographic Variations in Demographics, Socioeconomic Status, and Stage at Diagnosis Among Hormone Receptor–positive Invasive Ductal Carcinoma: An NCDB Analysis (2004-2020)
  • Neck Dissection and Immune Checkpoint Inhibitor Efficacy in Head and Neck Cancer: A Retrospective Study
Show more Clinical Studies

Keywords

  • bevacizumab
  • Colorectal cancer
  • predictive marker
  • proteinuria
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire